We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

489 hedge funds and large institutions have $4.31B invested in iShares US Medical Devices ETF in 2020 Q3 according to their latest regulatory filings, with 73 funds opening new positions, 219 increasing their positions, 123 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more repeat investments, than reductions

Existing positions increased: 219 | Existing positions reduced: 123

55% more first-time investments, than exits

New positions opened: 73 | Existing positions closed: 47

24% more capital invested

Capital invested by funds: $3.48B → $4.31B (+$836M)

13% more funds holding in top 10

Funds holding in top 10: 2326 (+3)

4.83% more ownership

Funds ownership: 311.54%316.37% (+4.8%)

4% more funds holding

Funds holding: 468489 (+21)

85% less call options, than puts

Call options by funds: $13.3M | Put options by funds: $85.7M

Holders
489
Holders Change
+21
Holders Change %
+4.49%
% of All Funds
9.87%
Holding in Top 10
26
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+13.04%
% of All Funds
0.52%
New
73
Increased
219
Reduced
123
Closed
47
Calls
$13.3M
Puts
$85.7M
Net Calls
-$72.4M
Net Calls Change
-$13.7M
Name Holding Trade Value Shares
Change
Change in
Stake
MCM
151
Murphy Capital Management
New Jersey
$2.85M -$5.52K -114 -0.2%
AIM
152
Anchor Investment Management
South Carolina
$2.8M +$741K +15,300 +38%
I
153
INVST
Indiana
$2.71M +$283K +5,838 +12%
BWP
154
Bernardo Wealth Planning
Pennsylvania
$2.67M +$116K +2,388 +5%
CA
155
Cetera Advisors
Colorado
$2.65M -$395K -8,160 -13%
TSA
156
Tri-Star Advisors
Texas
$2.57M +$211K +4,362 +10%
SFS
157
Sowell Financial Services
Arkansas
$2.56M +$149K +3,072 +6%
MAFM
158
Mid Atlantic Financial Management
Pennsylvania
$2.53M -$81.6K -1,686 -3%
OCM
159
Orleans Capital Management
Louisiana
$2.52M +$142K +2,940 +6%
AF
160
Advisornet Financial
Minnesota
$2.5M +$13.7K +282 +0.6%
FCA
161
FLC Capital Advisors
California
$2.47M +$353K +7,284 +18%
RFWA
162
RPg Family Wealth Advisory
Massachusetts
$2.46M +$36.6K +756 +2%
CWM
163
Concentrum Wealth Management
California
$2.46M +$331K +6,834 +16%
FEM
164
Fulcrum Equity Management
Texas
$2.32M +$2.02M +41,712 +865%
DC
165
Davenport & Co
Virginia
$2.3M +$74.4K +1,536 +3%
HW
166
Hamilton Wealth
California
$2.28M -$50.3K -1,038 -2%
FLAM
167
First Light Asset Management
Minnesota
$2.27M
DWM
168
Destination Wealth Management
California
$2.27M -$34.6K -714 -2%
SSWM
169
Sheets Smith Wealth Management
North Carolina
$2.25M -$160K -3,312 -7%
HGWM
170
Horst & Graben Wealth Management
Oregon
$2.23M +$486K +10,026 +29%
CAM
171
Cypress Asset Management
Texas
$2.22M -$10.2K -210 -0.5%
CAG
172
Csenge Advisory Group
Florida
$2.21M -$5.69M -117,444 -73%
LWM
173
Liberty Wealth Management
California
$2.19M +$354K +7,314 +20%
FFN
174
Focus Financial Network
Minnesota
$2.17M +$527K +10,878 +33%
JMPWA
175
JP Morgan Private Wealth Advisors
California
$2.14M +$214K +4,428 +12%

IHI Hedge Fund Activity: Q3 2020 in Review

489 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q3 2020, worth a combined $4.31B — up 24% from $3.48B a quarter earlier.

Buyers outnumbered sellers: 73 funds opened new IHI positions and 47 closed out — a net gain of 26 holders — while 219 added to existing stakes and 123 trimmed.

The largest buyer was Churchill Management, adding an estimated $175M. The largest seller was Morgan Stanley, cutting an estimated $202M.

  • 489 institutional investors held iShares US Medical Devices ETF (IHI) as of Q3 2020, up from 468 in Q2 2020.
  • Funds reported $4.31B of iShares US Medical Devices ETF stock for Q3 2020, up 24% quarter-over-quarter.
  • 73 funds opened new iShares US Medical Devices ETF positions in Q3 2020 and 47 closed out, a net change of +26 holders.
  • The largest iShares US Medical Devices ETF buyer in Q3 2020 was Churchill Management, an estimated $175M added.
  • The largest iShares US Medical Devices ETF seller in Q3 2020 was Morgan Stanley, an estimated $202M sold.

Based on aggregated 13F filings for Q3 2020.